A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01114841
Recruitment Status : Completed
First Posted : May 3, 2010
Last Update Posted : June 14, 2017
Information provided by (Responsible Party):
GlaxoSmithKline ( Stiefel, a GSK Company )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 26, 2010
  Actual Study Completion Date : June 26, 2010
Jeff Berg, Jim Bowman, Alessandra Alio. The Cumulative Irritation and Contact Sensitization Potential of Topical Tazarotene Foam, 0.1% in 2 Single-Center, Evaluator-Blinded, Randomized Vehicle-Controlled Phase 1 Patch Studies in Healthy Volunteers (W0260-101& 102). Cutis. 2012;90(4):206-211.